An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Roche Molecular Systems, 1145 Atlantic Ave., Alameda, CA 94501, USA. Henry.Erlich@Roche.com
Authors
Bonella P, Carlson JA, Concannon P, Erlich H, Fear AL, Lavant E, Louey A, Moonsamy P, Mychaleckyj JC, Noble J, Todd JA, Type 1 Diabetes Genetics Consortium, Valdes AM, Varney M
Studies
Citation
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P, Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008 Apr;57(4):1084-92. Epub 2008 Feb 5.Abstract
The Type 1 Diabetes Genetics Consortium has collected type 1 diabetic families worldwide for genetic analysis. The major genetic determinants of type 1 diabetes are alleles at the HLA-DRB1 and DQB1 loci, with both susceptible and protective DR-DQ haplotypes present in all human populations. The aim of this study is to estimate the risk conferred by specific DR-DQ haplotypes and genotypes.